Erick Strauss, Ph.D.
Affiliations: | 2003 | Cornell University, Ithaca, NY, United States |
Area:
Barton Professor of ChemistryGoogle:
"Erick Strauss"Mean distance: 8.55 | S | N | B | C | P |
Parents
Sign in to add mentor| Tadhg P. Begley | grad student | 2003 | Cornell | |
| (Thiols, radicals and antibiotics: Mechanistic studies in coenzyme A biosynthesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alkhalaf LM, Arrowsmith C, Balskus EP, et al. (2024) Thoughts for the future. Nature Chemical Biology. 21: 6-15 |
| Mostert KJ, Sharma N, van der Zwaag M, et al. (2021) The Coenzyme A Level Modulator Hopantenate (HoPan) Inhibits Phosphopantotenoylcysteine Synthetase Activity. Acs Chemical Biology |
| Spry C, Barnard L, Kok M, et al. (2020) Towards a stable and potent coenzyme A-targeting antiplasmodial agent: structure-activity relationship studies of N-phenethyl-α-methyl-pantothenamide. Acs Infectious Diseases |
| Sharma N, Ahalawat N, Sandhu P, et al. (2020) Role of allosteric switches and adaptor domains in long-distance cross-talk and transient tunnel formation. Science Advances. 6: eaay7919 |
| Domingo R, van der Westhuyzen R, Hamann AR, et al. (2019) Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801. Medchemcomm. 10: 2118-2125 |
| Guan J, Barnard L, Cresson J, et al. (2018) Probing the ligand preferences of the three types of bacterial pantothenate kinase. Bioorganic & Medicinal Chemistry |
| Santolaria C, Velázquez D, Strauss E, et al. (2018) Mutations at the hydrophobic core affect Hal3 trimer stability, reducing its Ppz1 inhibitory capacity but not its PPCDC moonlighting function. Scientific Reports. 8: 14701 |
| Tjhin ET, Spry C, Sewell AL, et al. (2018) Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues. Plos Pathogens. 14: e1006918 |
| Barnard L, Mostert KJ, van Otterlo WAL, et al. (2018) Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action. Acs Infectious Diseases |
| de Villiers M, Spry C, Macuamule CJ, et al. (2017) Antiplasmodial mode of action of pantothenamides: pantothenate kinase serves as a metabolic activator, not as a target. Acs Infectious Diseases |